source
- Alphabet’s Isomorphic Labs draws VC interest as it seeks to turn AI protein modeling into drug discovery engineIsomorphic Labs, an Alphabet spin‑off, is building a platform that uses its protein‑modeling AI to create new medicines. The secretive startup has not been actively raising money, but venture firm…
- Nouscom secures $135 million Series D to advance lead cancer vaccine into Phase 2Clinical-stage biotech Nouscom announced it has closed a $135 million Series D financing round that was oversubscribed. The capital will be used to move its lead cancer vaccine candidate into a Pha…